Growth Metrics

Emergent BioSolutions (EBS) Intangibles (2016 - 2026)

Emergent BioSolutions has reported Intangibles over the past 14 years, most recently at $470.4 million for Q1 2026.

  • For Q1 2026, Intangibles fell 3.05% year-over-year to $470.4 million; the TTM value through Mar 2026 reached $470.4 million, down 3.05%, while the annual FY2025 figure was $436.5 million, 12.96% down from the prior year.
  • Intangibles for Q1 2026 was $470.4 million at Emergent BioSolutions, up from $436.5 million in the prior quarter.
  • Over five years, Intangibles peaked at $728.8 million in Q4 2022 and troughed at $436.5 million in Q4 2025.
  • A 5-year average of $552.3 million and a median of $550.4 million in 2024 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: increased 20.54% in 2022 and later decreased 22.26% in 2023.
  • Year by year, Intangibles stood at $728.8 million in 2022, then fell by 22.26% to $566.6 million in 2023, then dropped by 11.49% to $501.5 million in 2024, then decreased by 12.96% to $436.5 million in 2025, then grew by 7.77% to $470.4 million in 2026.
  • Business Quant data shows Intangibles for EBS at $470.4 million in Q1 2026, $436.5 million in Q4 2025, and $452.7 million in Q3 2025.